SCHEMBL14616303

SCHEMBL14616303

C=C(C)C(=O)OC(C)CNC(=O)c1ccc(CC)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
PLK1 P53350 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
LMNA P02545 3/20 0.41
TAOK1 Q7L7X3 2/20 0.41
TAOK3 Q9H2K8 2/20 0.41
NAMPT P43490 1/20 0.40
MAPK1 P28482 2/20 0.40
NLRP1 Q9C000 1/20 0.40
ACACB O00763 1/20 0.39
MLYCD O95822 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12332153 0.86 NPSR1 (0.46) HPGDNPSR1MEN1KMT2AALDH1A1
SCHEMBL13919830 0.80 ALDH1A1 (0.54) HPGDNPSR1PLK1MEN1KMT2A
SCHEMBL10268332 0.77 HPGD (0.64) HPGDNPSR1PLK1KMT2AALDH1A1
SCHEMBL12332295 0.76 ADRB2 (0.41) HPGDNPSR1MEN1KMT2AALDH1A1
SCHEMBL12332426 0.75 PLK1 (0.58) HPGDNPSR1PLK1MEN1KMT2A
SCHEMBL17208757 0.74 PLK1 (0.59) HPGDNPSR1PLK1MEN1KMT2A
SCHEMBL12358256 0.73 MTNR1A (0.45) ALDH1A1MAPK1
SCHEMBL16309295 0.73 TSHR (0.42) MEN1KMT2AALDH1A1
SCHEMBL18469618 0.73 TDP1 (0.61) HPGDNPSR1PLK1MEN1KMT2A
SCHEMBL13159542 0.72 CYP4F2 (0.39) HPGDPLK1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785627-B2 Copolymerizable methine and anthraquinone compounds and articles containing them Abbott Medical Optics Inc. (US) 2014-07-22 US disclosed
US-8785627-B2 Copolymerizable methine and anthraquinone compounds and articles containing them Abbott Medical Optics Inc. (US) 2014-07-22 US disclosed
US-8501890-B2 Copolymerizable methine and anthraquinone compounds and articles containing them Abbott Medical Optics Inc. (US) 2013-08-06 US disclosed
US-8501890-B2 Copolymerizable methine and anthraquinone compounds and articles containing them Abbott Medical Optics Inc. (US) 2013-08-06 US disclosed
US-8360576-B2 Copolymerizable methine and anthraquinone compounds and articles containing them Abbott Medical Optics Inc. (US) 2013-01-29 US disclosed
US-8360576-B2 Copolymerizable methine and anthraquinone compounds and articles containing them Abbott Medical Optics Inc. (US) 2013-01-29 US disclosed
US-20130018159-A1 COPOLYMERIZABLE METHINE AND ANTHRAQUINONE COMPOUNDS AND ARTICLES CONTAINING THEM Abbott Medical Optics Inc. (US) 2013-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018159-A1 COPOLYMERIZABLE METHINE AND ANTHRAQUINONE COMPOUNDS AND ARTICLES CONTAINING THEM CRY1, AAAS, CYBA HPGD 491/4885NPSR1 4572/4885PLK1 1720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.